Skip Nav Destination
Issues
1 December 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editor's Note
The Biology Behind
CCR Drug Updates
Human Cancer Biology
Identification of a Novel Estrogen-Regulated Gene, EIG121, Induced by Hormone Replacement Therapy and Differentially Expressed in Type I and Type II Endometrial Cancer
Lei Deng; Russell R. Broaddus; Adrienne McCampbell; Gregory L. Shipley; David S. Loose; George M. Stancel; James H. Pickar; Peter J.A. Davies
Differing DNA Methylation Patterns and Gene Mutation Frequencies in Colorectal Carcinomas from Middle Eastern Countries
Annie O. Chan; Amr S. Soliman; Qing Zhang; Asif Rashid; Ahmed Bedeir; P. Scott Houlihan; Nadia Mokhtar; Nidal Al-Masri; Ugur Ozbek; Rami Yaghan; Ayten Kandilci; Sherif Omar; Yersu Kapran; Ferhunde Dizdaroglu; Melissa L. Bondy; Christopher I. Amos; Jean-Pierre Issa; Bernard Levin; Stanley R. Hamilton
Imaging, Diagnosis, Prognosis
The Expression of the Regulatory T Cell–Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian Cancer
Dominik Wolf; Anna M. Wolf; Holger Rumpold; Heidi Fiegl; Alain G. Zeimet; Elisabeth Muller-Holzner; Martina Deibl; Guenther Gastl; Eberhard Gunsilius; Christian Marth
Microsatellite Instability and Colorectal Cancer Prognosis
Piero Benatti; Roberta Gafà; Daniela Barana; Massimiliano Marino; Alessandra Scarselli; Monica Pedroni; Iva Maestri; Laura Guerzoni; Luca Roncucci; Mirco Menigatti; Barbara Roncari; Stefania Maffei; Giuseppina Rossi; Giovanni Ponti; Alessandra Santini; Lorena Losi; Carmela Di Gregorio; Cristina Oliani; Maurizio Ponz de Leon; Giovanni Lanza
High Cyclooxygenase-2 Expression Following Neoadjuvant Radiochemotherapy Is Associated with Minor Histopathologic Response and Poor Prognosis in Esophageal Cancer
Huan Xi; Stephan E. Baldus; Ute Warnecke-Eberz; Jan Brabender; Susanne Neiss; Ralf Metzger; Frederike C. Ling; Hans P. Dienes; Elfriede Bollschweiler; Stefan Moenig; Rolf P. Mueller; Arnulf H. Hoelscher; Paul M. Schneider
Expression of HER2 and the Coamplified Genes GRB7 and MLN64 in Human Breast Cancer: Quantitative Real-time Reverse Transcription-PCR as a Diagnostic Alternative to Immunohistochemistry and Fluorescence In situ Hybridization
Ursula Vinatzer; Brigitta Dampier; Berthold Streubel; Margit Pacher; Michael J. Seewald; Christian Stratowa; Klaus Kaserer; Martin Schreiber
Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo
Nicole Concin; Gerda Hofstetter; Astrid Berger; Adriana Gehmacher; Daniel Reimer; Rafal Watrowski; Dan Tong; Eva Schuster; Lukas Hefler; Kurt Heim; Elisabeth Mueller-Holzner; Christian Marth; Ute M. Moll; Alain G. Zeimet; Robert Zeillinger
Subcellular Localization and Protein Levels of Cyclin-Dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer
Amanda Psyrri; Aris Bamias; Ziwei Yu; Paul M. Weinberger; Mohamad Kassar; Sophia Markakis; Diane Kowalski; Eleni Efstathiou; Robert L. Camp; David L. Rimm; Meletios A. Dimopoulos
Cancer Therapy: Clinical
The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer
Thomas A. Buchholz; Amit K. Garg; Nitin Chakravarti; Bharat B. Aggarwal; Francisco J. Esteva; Henry M. Kuerer; S. Eva Singletary; Gabriel N. Hortobagyi; Lajos Pusztai; Massimo Cristofanilli; Aysegul A. Sahin
Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-d-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias
Judith E. Karp; Antonino Passaniti; Ivana Gojo; Scott Kaufmann; Keith Bible; Tushar S. Garimella; Jacqueline Greer; Janet Briel; B. Douglas Smith; Steven D. Gore; Michael L. Tidwell; Douglas D. Ross; John J. Wright; A. Dimitrios Colevas; Kenneth S. Bauer
Cancer Therapy: Preclinical
Combination Immunotherapy with Clinical-Scale Enriched Human γδ T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma
Mario Otto; Raymond C. Barfield; William J. Martin; Rekha Iyengar; Wing Leung; Thasia Leimig; Stanley Chaleff; Stephen D. Gillies; Rupert Handgretinger
In vitro and In vivo Clinical Pharmacology of Dimethyl Benzoylphenylurea, a Novel Oral Tubulin-Interactive Agent
Michelle A. Rudek; Ming Zhao; Nicola F. Smith; Robert W. Robey; Ping He; Gurulingappa Hallur; Saeed Khan; Manuel Hidalgo; Antonio Jimeno; A. Dimitrios Colevas; Wells A. Messersmith; Antonio C. Wolff; Sharyn D. Baker
Cancer Prevention
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds